231 related articles for article (PubMed ID: 24440048)
1. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.
Desai A; Webb B; Gerson SL
Radiother Oncol; 2014 Mar; 110(3):538-45. PubMed ID: 24440048
[TBL] [Abstract][Full Text] [Related]
2. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
3. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation.
Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO
Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130
[TBL] [Abstract][Full Text] [Related]
4. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
McCord AM; Jamal M; Williams ES; Camphausen K; Tofilon PJ
Clin Cancer Res; 2009 Aug; 15(16):5145-53. PubMed ID: 19671863
[TBL] [Abstract][Full Text] [Related]
5. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.
Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
[TBL] [Abstract][Full Text] [Related]
6. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
8. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.
Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439
[TBL] [Abstract][Full Text] [Related]
9. High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells.
Sun JC; He F; Yi W; Wan MH; Li R; Wei X; Wu R; Niu DL
Genet Mol Res; 2015 Dec; 14(4):18110-20. PubMed ID: 26782458
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor.
Chiou SH; Kao CL; Chen YW; Chien CS; Hung SC; Lo JF; Chen YJ; Ku HH; Hsu MT; Wong TT
PLoS One; 2008 May; 3(5):e2090. PubMed ID: 18509505
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
12. The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells.
Wu H; Chen Q; Zhang Y; Wu G; Meng R; Cheng J
J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):750-754. PubMed ID: 23073808
[TBL] [Abstract][Full Text] [Related]
13. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
15. Chk1 knockdown confers radiosensitization in prostate cancer stem cells.
Wang X; Ma Z; Xiao Z; Liu H; Dou Z; Feng X; Shi H
Oncol Rep; 2012 Dec; 28(6):2247-54. PubMed ID: 23027394
[TBL] [Abstract][Full Text] [Related]
16. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
Liu J; Mao Z; Huang J; Xie S; Liu T; Mao Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):670-5. PubMed ID: 24502949
[TBL] [Abstract][Full Text] [Related]
17. Effects of heterochromatin in colorectal cancer stem cells on radiosensitivity.
Chen T; Zhang Y; Guo WH; Meng MB; Mo XM; Lu Y
Chin J Cancer; 2010 Mar; 29(3):270-6. PubMed ID: 20193109
[TBL] [Abstract][Full Text] [Related]
18. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.
Meng X; Li M; Wang X; Wang Y; Ma D
Cancer Sci; 2009 Jun; 100(6):1040-6. PubMed ID: 19385971
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of 14-3-3ζ enhances radiosensitivity and radio-induced apoptosis in CD133(+) liver cancer stem cells.
Lee YK; Hur W; Lee SW; Hong SW; Kim SW; Choi JE; Yoon SK
Exp Mol Med; 2014 Feb; 46(2):e77. PubMed ID: 24556826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]